| (210) | Number of the EPO application | 17729822 |
| (220) | Filing date of the EPO application | 2017.06.01 |
| (80) | EPO patent specification publication (B) | EPB nr. 46/2019, 2019.11.13 |
| (110) | EPO patent number | 3435980 |
| (11) | Number of the document | MD 3435980 T2 |
| (21) | Number of the application | e 2019 0164 |
| (71) | Name(s) of applicant(s), code of the country | Helsinn Healthcare SA, CH; |
| (72) | Name(s) of inventor(s), code of the country | VENTURINI Alessio, IT;
CANNELLA Roberta, IT; |
| (73) | Name(s) of owner(s), code of the country | HELSINN Healthcare SA, CH; |
| (54) | Title of the invention | Physiologically balanced injectable formulations of fosnetupitant |
| (13) | Kind-of-document code | T2 |
| (51) | International Patent Classification | A61K 9/08 (2006.01.01); A61K 9/19 (2006.01.01); A61K 47/18 (2017.01.01); A61K 47/26 (2006.01.01); A61K 31/675 (2006.01.01); A61K 31/473 (2006.01.01); A61P 1/08 (2006.01.01) |
| (19) | Country | CH |
| (41) | Date of publication of the application | 2019.03.31 |
| (49) | Date of publication of the translation of the validated European patent specification | 2020.03.31 |
| (30) | Priority | 201662345942 P, 2016.06.06, US |
| (74) | Patent attorney | (Procedură) SIMANENKOVA Tatiana, Str. Andrei Doga 2/1, MD-2024, Chişinău, Republica Moldova |
| (86) | International application | PCT/EP2017/063268, 2017.06.01 |
| (87) | International publication | WO 2017/211663, 2017.12.14 |